Torrent Pharmaceuticals Limited (TORNTPHARM) — Board Meeting | 29 June 2025(2 announcements)
Torrent Pharmaceuticals announced a multi-step acquisition of J.B. Chemicals & Pharmaceuticals Limited, agreeing to purchase a 46.39% stake from KKR for INR 1,600 per share (totaling INR 11,917 crore), with plans to acquire an additional 2.80% from employees and launch a mandatory open offer for up to 26% of the expanded share capital at INR 1,639.18 per share, while also proposing a merger through a scheme of arrangement to enhance market position and operational synergies.
Torrent Pharmaceuticals announced a multi-step acquisition of J.B. Chemicals & Pharmaceuticals Limited, agreeing to purchase a 46.39% stake from KKR for INR 1,600 per share (totaling INR 11,917 crore), with a potential 2.80% employee buy-in and a mandatory open offer for up to 26% of the enlarged share capital at INR 1,639.18 per share, while also proposing a scheme of amalgamation that requires regulatory approvals including CCI, SEBI, and stock exchanges, targeting a fully diluted valuation of INR 25,689 crore to expand its product portfolio, market reach, and CDMO capabilities.
About Torrent Pharmaceuticals Limited (TORNTPHARM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when TORNTPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track TORNTPHARM — Free💡 Ask AI about this filing
📊 More TORNTPHARM filings
- Announcement — 11 August 2026 Torrent Pharmaceuticals announced its participation in an investors' meet hosted by Emkay on August ...
- Announcement — 11 August 2026 Torrent Pharmaceuticals announced that NSE Sustainability Ratings and Analytics assigned the company...
- 🔴 Financial Results — 4 August 2026 Torrent Pharmaceuticals announced a conference call transcript for Q1 FY26 results on August 4, 2026...
- 🟡 Board Meeting — 1 August 2026 Torrent Pharmaceuticals announced the cessation of Ameera Shah as an Independent Director effective ...
- 🔴 Financial Results — 30 July 2026 Torrent Pharmaceuticals announced that the audio recording of its conference call discussing financi...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when TORNTPHARM files new disclosures
Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track TORNTPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research